NHC: financial statements from SEC — TradeAlmanac

NHC

National HealthCare Corporation: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	1.52bn	1.31bn
Operating expenses	1.39bn	1.22bn
Operating income	128m	90m
Interest expense	—	4m
Pre-tax income	162m	136m
Income tax	40m	34m
Net income	120m	102m
Earnings per share	7.76	6.62
Earnings per share, diluted	7.67	6.53
Weighted average shares	15m	15m
Weighted average shares, diluted	16m	16m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	86m	93m	131m	111m	90m	76m	85m	136m
Receivables	138m	139m	132m

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	185m	107m
Depreciation and amortisation	45m	42m
Share-based compensation	4m	4m
Capital expenditure	36m	28m
Investing cash flow	−34m	−237m
Dividends paid	39m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)